Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer

NCT01843049 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

RADIATION: Radiotherapy
DRUG: Chemotherapy (5-FU+DDP)

Sponsor

Fudan University